New funding for Hungary’s Healthcare Network offers opportunities for U.S. healthcare and MedTech companies.

China’s market for hospitals and senior center construction is large and growing, but government limits on procurement pose a challenge for U.S. firms.

The Singapore Ministry of Health Standards Drug List, highlights the addition of sixteen antiretroviral drugs. 

Tanzania is a country with many patients presenting HPV related cancers. 

China eases regulations on over the counter (OTC) medicine as consumer demands for self-medication and preventative care drugs provide market opportunities.

The healthcare market in China and Hong Kong is experiencing significant growth. 

The Saudi Arabia  2030 Vision for Healthcare Embraces Public-Private Partnerships. 

Positive regulatory changes in Algeria’s pharmaceutical industry support American companies interested in the country’s pharmaceutical sector. 

As advanced manufacturing increases in New Zealand, opportunities exist for U.S. companies. 

Singapore will license Telemedicine in mid-2022 under the new Health Services Act.

A new regulatory body in Panama will oversee food imports and phytosanitary standards.

Major changes in Spain’s eHealth environment offers opportunities for U.S. healthcare technologies.  

U.S. companies who are interested in exporting to Singapore may consider appointing a local distributor to represent their company’s product and services.

ICT solutions can play an important role in improving healthcare delivery to individuals and communities especially in the rural areas.

New fees for sanitary licenses in Guatemala affect pharmaceutical and cosmetic products.